Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,313 | -7,276 | -7,167 | -4,637 | -2,566 |
| Depreciation Amortization | 449 | 1,867 | 1,410 | 929 | 445 |
| Accounts receivable | 565 | -1,991 | -197 | 53 | -1,099 |
| Accounts payable and accrued liabilities | -565 | 465 | -578 | -800 | 424 |
| Other Working Capital | -1,927 | -3,823 | -596 | -971 | -2,725 |
| Other Operating Activity | 476 | 4,621 | 2,807 | 2,024 | 1,530 |
| Operating Cash Flow | $311 | $-6,137 | $-4,321 | $-3,402 | $-3,991 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -836 | -839 | -747 | -668 |
| Investing Cash Flow | $N/A | $-836 | $-839 | $-747 | $-668 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -37 | -146 | -108 | -74 | N/A |
| Common Stock Issued | N/A | 253 | 252 | 252 | 12 |
| Common Stock Repurchased | N/A | -634 | -634 | -634 | -602 |
| Financing Cash Flow | $-37 | $-527 | $-490 | $-456 | $-590 |
| Beginning Cash Position | 2,618 | 10,118 | 10,118 | 10,118 | 10,118 |
| End Cash Position | 2,892 | 2,618 | 4,468 | 5,513 | 4,869 |
| Net Cash Flow | $274 | $-7,500 | $-5,650 | $-4,605 | $-5,249 |
| Free Cash Flow | |||||
| Operating Cash Flow | 311 | -6,137 | -4,321 | -3,402 | -3,991 |
| Capital Expenditure | N/A | -836 | -839 | -747 | -668 |
| Free Cash Flow | 311 | -6,973 | -5,160 | -4,149 | -4,659 |